GLSI(GLSI)
GLSI
ANALYST COVERAGE2 analysts
BUY
▲ +86.0%upside to target
PRICE
Prev Close
27.21
Open
27.21
Day Range26.60 – 28.00
26.60
28.00
52W Range7.78 – 34.10
7.78
34.10
73% of range
VOLUME & SIZE
Avg Volume
156.4K
FUNDAMENTALS
P/E Ratio
-18.4x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.15
Market-like
TECHNICAL
RSI (14)
55
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 97 days
Aug 24
Key MetricsTTM
Market Cap$372.41M
Revenue TTM$0.00
Net Income TTM-$19.48M
Free Cash Flow-$8.59M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-1042.8%
Return on Assets-511.6%
Debt / Equity0.00
Current Ratio2.35
EPS TTM$-1.43
GLSI News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Christine T. FischetteVice President of Business Development
Frank Joseph DaughertyChief Medical Officer & Director
Jaye L. ThompsonVice President Clinical & Regulatory Affairs
Eric RotheFounder & Independent Director
Snehal S. PatelChief Executive Officer, Chief Financial Officer & Director